Kristina Masson - Nov 14, 2023 Form 4 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
EVP - Business Operations, Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Nov 14, 2023
Transactions value $
-$9,652
Form type
4
Date filed
11/16/2023, 07:42 PM
Previous filing
Nov 16, 2022
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRV Common Stock Tax liability -$9.65K -1.9K -0.59% $5.08 319K Nov 14, 2023 Direct F1
holding ACRV Common Stock 2.66M Nov 14, 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
F2 These securities are held by President and CEO, Peter Blume-Jensen, who is also Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney